Abstract:SESSION TITLE: Chest Infections: Bronchieactasis SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: Bronchiectasis revealed by chest computed tomography in COPD patients and its comorbid effect on prognosis have not been addressed by large-sized studies. Understanding the presence of bronchiectasis in COPD is important for future intervention and preventing disease progress. METHODS: Observational studies were identified from electronic literature searches in Cochrane library, Pubmed, Sciencedirect databases, American Thoracic Society and European Respiratory Society meeting abstracts. A systematic review and meta-analysis of studies was performed to summarize the factors associated with bronchiectasis in patients with COPD. Primary outcomes included the risks of exacerbation frequency, isolation of a potentially pathogenic microorganism, severe airway obstruction and mortality. Odds ratios (ORs) were pooled by random effects models. RESULTS: Fourteen observational studies were eligible for the study. Compared with COPD without bronchiectasis, comorbid bronchiectasis increased the risk for exacerbation (1.97, 95% CI, 1.29-3.00), isolation of a potentially pathogenic microorganism (4.11, 95%CI, 2.16-7.82), severe airway obstruction (1.31, 95% CI, 1.09-1.58) and mortality (1.75, 95% CI, 1.14-2.68). CONCLUSIONS: The presence of bronchiectasis in patients with COPD was associated with exacerbation frequency, isolation of a potentially pathogenic microorganism, severe airway obstruction and mortality. These associations suggest potential usefulness of screening for bronchiectasis in COPD patients for better interventions, especial in patients with advanced COPD or susceptible to frequent exacerbations. CLINICAL IMPLICATIONS: This study adds to the fast growing evidence of the association between bronchiectasis and poor outcomes in COPD, which has very important implications for our current practice and approach to the evaluation and management of COPD. More importantly, our study provides data supporting chest CT evaluation in the care of COPD patients, especial for those with severe disease and susceptible to exacerbations. DISCLOSURE: The following authors have nothing to disclose: Qingxia Du, Jianmin Jin, Xiaofang Liu, Yongchang Sun No Product/Research Disclosure Information

[Chronic Bronchial Infection in Stable COPD]

The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions

Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases

Clinical Characteristics of Patients with Chronic Obstructive Pulmonary Disease with Comorbid Bronchiectasis: A Systemic Review and Meta-analysis

Time to re-set our thinking about airways disease: lessons from history, the resurgence of chronic bronchitis / PBB and modern concepts in microbiology

Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease

Rethinking bronchiectasis as an inflammatory disease

The microbiome in bronchiectasis

Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects

[Chronic bronchitis, COPD]

The roles of bacteria and viruses in COPD-Bronchiectasis association: A prospective cohort study

Bacterial vaccines in chronic obstructive pulmonary disease: effects on clinical outcomes and cytokine levels

Role Of Subacute Bronchial Infection In Patients With Severe Asthma Candidates For Biologic Therapy

Bacterial Infection, Airway and Systemic Inflammation and Clinical Outcomes Before and after Treatment of AECOPD, a Longitudinal and Cross-Sectional Study.

Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians

Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review

Inhaled Antibiotic Therapy in Chronic Respiratory Diseases

Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease

Respiratory Pathogens at Exacerbation in Chronic Bronchitis With Airway Bacterial Colonisation: A Cohort Study

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Pseudomonas aeruginosa